Patent Oppositions in animal or human proteins industry

Explore the competitive field of animal or human proteins where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in animal or human proteins technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the animal or human proteins industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the animal or human proteins industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 23, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Ph Neutral Beta-Lactoglobulin Beverage PreparationARLA FOODS AMBAJun 24, 2026NUTRICIA
Ph Neutral Beta-Lactoglobulin Beverage PreparationARLA FOODS AMBAJun 19, 2026ZIMMERMANN & PARTNER PATENTANWALTE MBB
Acidic Beta-Lactoglobulin Beverage PreparationARLA FOODS AMBAJun 17, 2026GLEISS GROSSE SCHRELL UND PARTNER MBB
Acidic Beta-Lactoglobulin Beverage PreparationARLA FOODS AMBAJun 16, 2026ZIMMERMANN & PARTNER PATENTANWALTE MBB
Ph Neutral Beta-Lactoglobulin Beverage PreparationARLA FOODS AMBAJun 16, 2026FRIESLANDCAMPINA NEDERLAND
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 3, 2026BOULT WADE TENNANT
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 2, 2026AMGEN
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 1, 2026ADVANZ PHARMA SERVICES UK
Liquid Composition Comprising Vegf AntagonistSAMSUNG BIOEPISFeb 16, 2026KILBURN & STRODE
Liquid Composition Comprising Vegf AntagonistSAMSUNG BIOEPISFeb 13, 2026KIVIAL

To stay ahead in the competitive animal or human proteins industry, companies are constantly innovating. Here are the top patents facing oppositions in the animal or human proteins industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 23, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Sep 3, 2025Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCARE10
Nov 3, 2021SyringeNOVARTIS7
Jan 5, 2022Treatment Of Age Related Macular Degeneration With A Small Active Choroidal Neovascularization LesionBAYER HEALTHCARE7
Aug 10, 2022Use Of A Vegf Antagonist To Treat Angiogenic Eye DisordersREGENERON PHARMACEUTICALS5
Sep 14, 2022Liquid Enteral Nutritional Composition With A Low Monovalent Metal Ion ContentNUTRICIA5
Oct 26, 2022Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or AgonistOSSIFI MAB5
Sep 24, 2025Ph Neutral Beta-Lactoglobulin Beverage PreparationARLA FOODS AMBA4
Apr 22, 2020Improved Methods For Manufacturing Adoptive Cell TherapiesSEVENTY BIO4
Feb 16, 2022SyringeNOVARTIS4
Apr 19, 2023Method For Producing Fusion Protein Having Igg Fc DomainALTEOGEN4